Paul Naumann

Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis

Xingshen Sun, Hongshu Sui, John T. Fisher et al. · Journal of Clinical Investigation · 2010 · 355 citations · Full text

Immunology, Gastroenterology, Pathology +16

Role of iron in T cell activation: Th1 clones differ from TH2 clones in their sensitivity to inhibition of DNA synthesis caused by IGG mabs against the transferrin receptor and the iron chelator deferoxamine

John Thorson, Kevin M. Smith, Francisco J. Gómez et al. · Cellular Immunology · 1991 · 99 citations

Th2 Clones, Iron Metabolism, T-regulatory Cell +9

Development and translational imaging of a TP53 porcine tumorigenesis model

Jessica C. Sieren, David K. Meyerholz, Xiaojun Wang et al. · Journal of Clinical Investigation · 2014 · 93 citations · Full text

Engineering, Oncologic Imaging, Pathology +23

Inhibition of lymphoma growth in vivo by combined treatment with hydroxyethyl starch deferoxamine conjugate and IgG monoclonal antibodies against the transferrin receptor.

John D. Kemp, Thomas M. Cardillo, Barbara Stewart et al. · PubMed · 1995 · 41 citations

Chemoprevention Strategy, Immunology, Synergistic Inhibition +17

Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity.

John D. Kemp, John Thorson, Barbara Stewart et al. · PubMed · 1992 · 37 citations

Hematological Malignancy, Tumor Biology, Igg Monoclonal Antibody +15